Congenital Goiter Due to Maternal Ingestion of Iodides
Among 22,843 infants delivered at the New York Hospital from January 1, 1966 to June 1, 1971, 2 had congenital goiters. One of these infants had been delivered vaginally while the other was delivered abdominally due to extreme hyperextension of the neck. Both infants were treated with thyroid hormon...
Gespeichert in:
Veröffentlicht in: | Obstetrics and gynecology (New York. 1953) 1972-06, Vol.39 (6), p.818-822 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 822 |
---|---|
container_issue | 6 |
container_start_page | 818 |
container_title | Obstetrics and gynecology (New York. 1953) |
container_volume | 39 |
creator | AYROMLOOI, JAHANGIR |
description | Among 22,843 infants delivered at the New York Hospital from January 1, 1966 to June 1, 1971, 2 had congenital goiters. One of these infants had been delivered vaginally while the other was delivered abdominally due to extreme hyperextension of the neck. Both infants were treated with thyroid hormone for two reasonsa) to suppress thyroid stimulating hormone and therefore decrease the size of the goiter and b) to prevent mental retardation due to hypothyroidism. The interesting finding in these cases was the long term history of maternal ingestion of iodine. It is therefore recommended that iodine-containing preparations not be used for extended periods during pregnancy. |
format | Article |
fullrecord | <record><control><sourceid>pubmed_wolte</sourceid><recordid>TN_cdi_pubmed_primary_5068335</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>5068335</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2512-54d4e27d0f7fe888383b0f1f4fe9bcc6c9d89c943c6e2fa7572e5c8c371df5303</originalsourceid><addsrcrecordid>eNotT9tKxDAUDKKs6-onCP2BQJqT66NUXQsrvij4VtrkxK12m9ILi39vZPdpmAvDzAVZ50YD5QCfl2TNGLdUGyGuyc00fTPGcmVhRVaSKQMg10QVsf_Cvp3rLtvGdsYxe1wwm2P2WifSJ7lMgWluY5_FkJXRtx6nW3IV6m7CuzNuyMfz03vxQndv27J42NGBy5xTKbxArj0LOqAxBgw0LORBBLSNc8pZb6yzApxCHmotNUfpjAOd-yCBwYbcn3qHpTmgr4axPdTjb3Xen3xx8o-xS3Onn2454ljtse7mfZX-MsUlo7nVnKnE6L_E4Q9WVlFG</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Congenital Goiter Due to Maternal Ingestion of Iodides</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>AYROMLOOI, JAHANGIR</creator><creatorcontrib>AYROMLOOI, JAHANGIR</creatorcontrib><description>Among 22,843 infants delivered at the New York Hospital from January 1, 1966 to June 1, 1971, 2 had congenital goiters. One of these infants had been delivered vaginally while the other was delivered abdominally due to extreme hyperextension of the neck. Both infants were treated with thyroid hormone for two reasonsa) to suppress thyroid stimulating hormone and therefore decrease the size of the goiter and b) to prevent mental retardation due to hypothyroidism. The interesting finding in these cases was the long term history of maternal ingestion of iodine. It is therefore recommended that iodine-containing preparations not be used for extended periods during pregnancy.</description><identifier>ISSN: 0029-7844</identifier><identifier>EISSN: 1873-233X</identifier><identifier>PMID: 5068335</identifier><language>eng</language><publisher>United States: The American College of Obstetricians and Gynecologists</publisher><subject>Apgar Score ; Bone Diseases, Developmental - etiology ; Cesarean Section ; Electroencephalography ; Female ; Fetus - drug effects ; Goiter - congenital ; Graves Disease - drug therapy ; Humans ; Hypothyroidism - drug therapy ; Infant, Newborn ; Iodides - adverse effects ; Labor Presentation ; Male ; Maternal-Fetal Exchange ; Potassium Iodide - administration & dosage ; Pregnancy ; Pregnancy Complications - drug therapy ; Propylthiouracil - therapeutic use ; Thyroid Function Tests ; Thyroid Hormones - therapeutic use ; Tracheal Stenosis - etiology ; Triiodothyronine - therapeutic use</subject><ispartof>Obstetrics and gynecology (New York. 1953), 1972-06, Vol.39 (6), p.818-822</ispartof><rights>1972 The American College of Obstetricians and Gynecologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/5068335$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AYROMLOOI, JAHANGIR</creatorcontrib><title>Congenital Goiter Due to Maternal Ingestion of Iodides</title><title>Obstetrics and gynecology (New York. 1953)</title><addtitle>Obstet Gynecol</addtitle><description>Among 22,843 infants delivered at the New York Hospital from January 1, 1966 to June 1, 1971, 2 had congenital goiters. One of these infants had been delivered vaginally while the other was delivered abdominally due to extreme hyperextension of the neck. Both infants were treated with thyroid hormone for two reasonsa) to suppress thyroid stimulating hormone and therefore decrease the size of the goiter and b) to prevent mental retardation due to hypothyroidism. The interesting finding in these cases was the long term history of maternal ingestion of iodine. It is therefore recommended that iodine-containing preparations not be used for extended periods during pregnancy.</description><subject>Apgar Score</subject><subject>Bone Diseases, Developmental - etiology</subject><subject>Cesarean Section</subject><subject>Electroencephalography</subject><subject>Female</subject><subject>Fetus - drug effects</subject><subject>Goiter - congenital</subject><subject>Graves Disease - drug therapy</subject><subject>Humans</subject><subject>Hypothyroidism - drug therapy</subject><subject>Infant, Newborn</subject><subject>Iodides - adverse effects</subject><subject>Labor Presentation</subject><subject>Male</subject><subject>Maternal-Fetal Exchange</subject><subject>Potassium Iodide - administration & dosage</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - drug therapy</subject><subject>Propylthiouracil - therapeutic use</subject><subject>Thyroid Function Tests</subject><subject>Thyroid Hormones - therapeutic use</subject><subject>Tracheal Stenosis - etiology</subject><subject>Triiodothyronine - therapeutic use</subject><issn>0029-7844</issn><issn>1873-233X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1972</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotT9tKxDAUDKKs6-onCP2BQJqT66NUXQsrvij4VtrkxK12m9ILi39vZPdpmAvDzAVZ50YD5QCfl2TNGLdUGyGuyc00fTPGcmVhRVaSKQMg10QVsf_Cvp3rLtvGdsYxe1wwm2P2WifSJ7lMgWluY5_FkJXRtx6nW3IV6m7CuzNuyMfz03vxQndv27J42NGBy5xTKbxArj0LOqAxBgw0LORBBLSNc8pZb6yzApxCHmotNUfpjAOd-yCBwYbcn3qHpTmgr4axPdTjb3Xen3xx8o-xS3Onn2454ljtse7mfZX-MsUlo7nVnKnE6L_E4Q9WVlFG</recordid><startdate>197206</startdate><enddate>197206</enddate><creator>AYROMLOOI, JAHANGIR</creator><general>The American College of Obstetricians and Gynecologists</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>197206</creationdate><title>Congenital Goiter Due to Maternal Ingestion of Iodides</title><author>AYROMLOOI, JAHANGIR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2512-54d4e27d0f7fe888383b0f1f4fe9bcc6c9d89c943c6e2fa7572e5c8c371df5303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1972</creationdate><topic>Apgar Score</topic><topic>Bone Diseases, Developmental - etiology</topic><topic>Cesarean Section</topic><topic>Electroencephalography</topic><topic>Female</topic><topic>Fetus - drug effects</topic><topic>Goiter - congenital</topic><topic>Graves Disease - drug therapy</topic><topic>Humans</topic><topic>Hypothyroidism - drug therapy</topic><topic>Infant, Newborn</topic><topic>Iodides - adverse effects</topic><topic>Labor Presentation</topic><topic>Male</topic><topic>Maternal-Fetal Exchange</topic><topic>Potassium Iodide - administration & dosage</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - drug therapy</topic><topic>Propylthiouracil - therapeutic use</topic><topic>Thyroid Function Tests</topic><topic>Thyroid Hormones - therapeutic use</topic><topic>Tracheal Stenosis - etiology</topic><topic>Triiodothyronine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AYROMLOOI, JAHANGIR</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AYROMLOOI, JAHANGIR</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Congenital Goiter Due to Maternal Ingestion of Iodides</atitle><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle><addtitle>Obstet Gynecol</addtitle><date>1972-06</date><risdate>1972</risdate><volume>39</volume><issue>6</issue><spage>818</spage><epage>822</epage><pages>818-822</pages><issn>0029-7844</issn><eissn>1873-233X</eissn><abstract>Among 22,843 infants delivered at the New York Hospital from January 1, 1966 to June 1, 1971, 2 had congenital goiters. One of these infants had been delivered vaginally while the other was delivered abdominally due to extreme hyperextension of the neck. Both infants were treated with thyroid hormone for two reasonsa) to suppress thyroid stimulating hormone and therefore decrease the size of the goiter and b) to prevent mental retardation due to hypothyroidism. The interesting finding in these cases was the long term history of maternal ingestion of iodine. It is therefore recommended that iodine-containing preparations not be used for extended periods during pregnancy.</abstract><cop>United States</cop><pub>The American College of Obstetricians and Gynecologists</pub><pmid>5068335</pmid><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0029-7844 |
ispartof | Obstetrics and gynecology (New York. 1953), 1972-06, Vol.39 (6), p.818-822 |
issn | 0029-7844 1873-233X |
language | eng |
recordid | cdi_pubmed_primary_5068335 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Apgar Score Bone Diseases, Developmental - etiology Cesarean Section Electroencephalography Female Fetus - drug effects Goiter - congenital Graves Disease - drug therapy Humans Hypothyroidism - drug therapy Infant, Newborn Iodides - adverse effects Labor Presentation Male Maternal-Fetal Exchange Potassium Iodide - administration & dosage Pregnancy Pregnancy Complications - drug therapy Propylthiouracil - therapeutic use Thyroid Function Tests Thyroid Hormones - therapeutic use Tracheal Stenosis - etiology Triiodothyronine - therapeutic use |
title | Congenital Goiter Due to Maternal Ingestion of Iodides |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A32%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_wolte&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Congenital%20Goiter%20Due%20to%20Maternal%20Ingestion%20of%20Iodides&rft.jtitle=Obstetrics%20and%20gynecology%20(New%20York.%201953)&rft.au=AYROMLOOI,%20JAHANGIR&rft.date=1972-06&rft.volume=39&rft.issue=6&rft.spage=818&rft.epage=822&rft.pages=818-822&rft.issn=0029-7844&rft.eissn=1873-233X&rft_id=info:doi/&rft_dat=%3Cpubmed_wolte%3E5068335%3C/pubmed_wolte%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/5068335&rfr_iscdi=true |